Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Clinical Trial

Systematic Review

Research Support, U.S. Gov't, P.H.S.

Research Support, N.I.H., Extramural

Controlled Clinical Trial

Meta-Analysis

Comment

Network Meta-Analysis

Randomized Controlled Trial

Editorial

Publication Year

From

Quick links

Individual year

2026

2025

2022

2020

2019

2018

2016

2015

2014

2010

2005

2004

2002

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Tetrabenazine""[mesh_terms]

18 Results

Searching titles within these results

An MDS Evidence-Based Review on Treatments for Huntington's Disease.

Joaquim J Ferreira, Filipe B Rodrigues, Gonçalo S Duarte, Tiago A Mestre, Anne-Catherine Bachoud-Levi, Anna Rita Bentivoglio, Jean-Marc Burgunder, Francisco Cardoso, Daniel O Claassen, G Bernard Landwehrmeyer, Jaime Kulisevsky, Melissa J Nirenberg, Anne Rosser, Jan Roth, Klaus Seppi, Jaroslaw Slawek, Erin Furr-Stimming, Sarah J Tabrizi, Francis O Walker, Wim Vandenberghe, João Costa, Cristina Sampaio

Movement disorders : official journal of the Movement Disorder Society 2022;37(1):25-35

Full Text

Abstract

Treatment options for chorea.

H Bashir, J Jankovic

Expert review of neurotherapeutics 2019;18(1):51-63

Full Text

Abstract

The pathophysiology and pharmacological treatment of Huntington disease.

Connie Pidgeon, Hugh Rickards

Behavioural neurology 2014;26(4):245-53

Free Full Text

Abstract

Tardive Dyskinesia: Treatment Update.

Divya Arya, Tarannum Khan, Adam J Margolius, Hubert H Fernandez

Current neurology and neuroscience reports 2020;19(9):69

Full Text

Abstract

Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [F]FP-DTBZ in Healthy Subjects and Patients with Type 1 Diabetes.

Mika Naganawa, Keunpoong Lim, Nabeel B Nabulsi, Shu-Fei Lin, David Labaree, Jim Ropchan, Kevan C Herold, Yiyun Huang, Paul Harris, Masanori Ichise, Gary W Cline, Richard E Carson

Molecular imaging and biology 2019;20(5):835-845

Free Full Text

Abstract

Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it?

A J Stoessl

Movement disorders : official journal of the Movement Disorder Society 2002;16(5):804-6

Full Text

¹⁸F-FP-(+)-DTBZ positron emission tomography detection of monoaminergic deficient network in patients with carbon monoxide related parkinsonism.

C-C Chang, I-T Hsiao, S-H Huang, C-C Lui, T-C Yen, W-N Chang, C-W Huang, C-J Hsieh, Y-Y Chang, K-J Lin

European journal of neurology 2015;22(5):845-52, e59-60

Full Text

Abstract

Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis.

Michele De Prisco, Andrea Cipriani, Michele Fornaro, Felice Iasevoli, Andrea de Bartolomeis, Cinzia Del Giovane, Marco Solmi, Christoph U Correll, Claudio Caiazza, Stefano Caiolo, Marialaura Lussignoli, Niccolo Solini, Giorgio Pigato

Molecular psychiatry 2025;30(3):1207-1222

Full Text

Abstract

Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent.

Kun-Ju Lin, Yi-Hsin Weng, Shiaw-Pyng Wey, Ing-Tsung Hsiao, Chin-Song Lu, Daniel Skovronsky, Hsiu-Ping Chang, Mei-Ping Kung, Tzu-Chen Yen

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(9):1480-5

Free Full Text

Abstract

Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.

Karla Soares-Weiser, John Rathbone, Yusuke Ogawa, Kiyomi Shinohara, Hanna Bergman

The Cochrane database of systematic reviews 2018;3(3):CD000208

Free Full Text

Abstract

Chronic manganism: A long-term follow-up study with a new dopamine terminal biomarker of 18F-FP-(+)-DTBZ (18F-AV-133) brain PET scan.

Chu-Yun Huang, Chi-Hung Liu, Eusden Tsao, Chia-Ju Hsieh, Yi-Hsin Weng, Ing-Tsung Hsiao, Tzu-Chen Yen, Kun-Ju Lin, Chin-Chang Huang

Journal of the neurological sciences 2016;353(1-2):102-6

Full Text

Abstract

Pharmacokinetics and Bioequivalence of 2 Deutetrabenazine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Dayong Xu, Pengkai Wang, Yuan Li, Ping Zhang, Liying Wei, Xiaolian Xiong, Xin Li

Clinical pharmacology in drug development 2026;15(3):e70054

Full Text

Abstract

Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.

Matthew J Freeby, Patricia Kringas, Robin S Goland, Rudolph L Leibel, Antonella Maffei, Chaitan Divgi, Masanori Ichise, Paul E Harris

Molecular imaging and biology 2016;18(2):292-301

Free Full Text

Abstract

The role of radiotracer imaging in Parkinson disease.

B Ravina, D Eidelberg, J E Ahlskog, R L Albin, D J Brooks, M Carbon, V Dhawan, A Feigin, S Fahn, M Guttman, K Gwinn-Hardy, H McFarland, R Innis, R G Katz, K Kieburtz, S J Kish, N Lange, J W Langston, K Marek, L Morin, C Moy, D Murphy, W H Oertel, G Oliver, Y Palesch, W Powers, J Seibyl, K D Sethi, C W Shults, P Sheehy, A J Stoessl, R Holloway

Neurology 2005;64(2):208-15

Full Text

Abstract

Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

Andrew McGarry, Michael P McDermott, Karl Kieburtz, Wai Lun Alan Fung, Elizabeth McCusker, Jing Peng, Elisabeth A de Blieck, Merit Cudkowicz

Neurology 2019;92(14):e1643-e1651

Free Full Text

Abstract

Results: 1 – 15 / 18

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Tetrabenazine""[mesh_terms]

An MDS Evidence-Based Review on Treatments for Huntington's Disease.

Treatment options for chorea.

The pathophysiology and pharmacological treatment of Huntington disease.

Tardive Dyskinesia: Treatment Update.

Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [F]FP-DTBZ in Healthy Subjects and Patients with Type 1 Diabetes.

Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it?

¹⁸F-FP-(+)-DTBZ positron emission tomography detection of monoaminergic deficient network in patients with carbon monoxide related parkinsonism.

Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis.

Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent.

Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.

Chronic manganism: A long-term follow-up study with a new dopamine terminal biomarker of 18F-FP-(+)-DTBZ (18F-AV-133) brain PET scan.

Pharmacokinetics and Bioequivalence of 2 Deutetrabenazine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.

The role of radiotracer imaging in Parkinson disease.

Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

Results for
""Tetrabenazine""[mesh_terms]